NEW YORK (GenomeWeb News) – Belgium’s AlgoNomics has entered into a research partnership with the Danish antibody company Genmab, the company announced today.
 
AlgoNomics plans to assist Genmab with detailed structural analysis of its fully human antibody molecules and antibody scaffolds, including Genmab’s new small, stable, modified antibody technology, UniBody.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.